Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Relapse remains the most common cause of treatment failure for patients with acute myeloid leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a grave prognosis. Multiple studies have identified the presence of measurable residual disease (MRD) assessed by flow cyt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Dillon, Richard, Hills, Robert, Freeman, Sylvie, Potter, Nicola, Jovanovic, Jelena, Ivey, Adam, Kanda, Anju Shankar, Runglall, Manohursingh, Foot, Nicola, Valganon, Mikel, Khwaja, Asim, Cavenagh, Jamie, Smith, Matthew, Ommen, Hans Beier, Overgaard, Ulrik Malthe, Dennis, Mike, Knapper, Steven, Kaur, Harpreet, Taussig, David, Mehta, Priyanka, Raj, Kavita, Novitzky-Basso, Igor, Nikolousis, Emmanouil, Danby, Robert, Krishnamurthy, Pramila, Hill, Kate, Finnegan, Damian, Alimam, Samah, Hurst, Erin, Johnson, Peter, Khan, Anjum, Salim, Rahuman, Craddock, Charles, Spearing, Ruth, Gilkes, Amanda, Gale, Rosemary, Burnett, Alan, Russell, Nigel H., Grimwade, David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059484/
https://ncbi.nlm.nih.gov/pubmed/31932839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados